EMJ Podcast: Insights For Healthcare Professionals

This is a non-promotional podcast funded and developed by AbbVie for healthcare professionals only. The content of this podcast is correct at the time of recording, which is December 2024. The views expressed in this podcast are those of the individual speakers and do not necessarily reflect the view of AbbVie or EMJ

If you are listening to this podcast through a podcast app, please note that any advertisements you may hear are not affiliated with this podcast or AbbVie in any way. To stop receiving podcast notifications, please unsubscribe from this series in your podcast player.

The Post-Stroke Spasticity Classification System was created and funded by AbbVie with the assistance of a group of international experts in the field of Post-Stroke Spasticity, utilising both published risk factors and their own clinical experience.

In this three-part series, Jonathan Sackier speaks with Peder Langeland Myhre about cutting-edge advancements in heart failure research, the importance of biomarker-driven care, the challenges of implementing digital health tools globally, and how Norway is reshaping participation in cardiology clinical trials.

Timestamps:

00:17 – Digital health equity

06:00 – Podcasts in medicine

07:59 – Three cardiology wishes

In this three-part series, Jonathan Sackier speaks with Peder Langeland Myhre about cutting-edge advancements in heart failure research, the importance of biomarker-driven care, the challenges of implementing digital health tools globally, and how Norway is reshaping participation in cardiology clinical trials.

Timestamps:

00:21 – Biomarker disparities

04:52 – Norway trial challenges

07:15 – Boosting trial engagement

In this three-part series, Jonathan Sackier speaks with Peder Langeland Myhre about cutting-edge advancements in heart failure research, the importance of biomarker-driven care, the challenges of implementing digital health tools globally, and how Norway is reshaping participation in cardiology clinical trials.

Timestamps:

02:06 – Skiing & heart

04:02 – Blix award impact

07:51 – Heart failure biomarkers

In this episode of the Onc Now Podcast, host Jonathan Sackier is joined by Janice Walshe, Consultant Medical Oncologist at St Vincent's University Hospital, Dublin, Ireland. They explore the economic realities of cancer diagnostics, fertility preservation in patients with breast cancer, and the impact of international collaboration on the future of clinical trials.

Timestamps:

00:00 – Introduction

03:25 – Economic disparities and oncology care in Ireland

07:20 – Neoadjuvant therapy for HER2-positive breast cancer

10:13 – Spotlight on invasive lobular carcinoma

12:36 – Fertility preservation in breast cancer

15:20 – Menopause after cancer

19:09 – The latest clinical trials in Ireland

21:50 – International trials and research projects

23:50 – Walshe's three wishes for healthcare

In this episode of Hema Now, Jonathan Sackier is joined by John Riches, Clinical Reader in Cancer Immunometabolism at the Barts Cancer Institute and Honorary Consultant Haemato-oncologist. They explore how metabolic shifts drive lymphoma progression, the potential of immunotherapy, and what the future holds for treating lymphoid malignancies.

Timestamps:

00:00 – Introduction

01:46 – Riches' journey into haematology

03:42 – What is T cell exhaustion?

07:06 – The key role of metabolism in lymphoma

09:33 - Richter's syndrome

13:17 – Breakthroughs in immunotherapy

20:27 – The challenges of translational research

25:39 – B cells in autoimmune diseases

28:16 – The potential of breath biopsy

32:58 – Riches' three wishes for healthcare

In the second episode of our miniseries on infectious disease diagnostics, Jonathan is joined by molecular epidemiologist Rodney Rohde, Regents' Professor at Texas State University, USA. Together, they explore diagnostic innovations in the fight against antimicrobial resistance, gaps in zoonotic disease detection, and the persistent challenge of vaccine hesitancy.

Timestamps:

00:00 – Introduction

01:45 – Breakthroughs in molecular diagnostics

08:30 – Diagnostic tools to combat superbugs

14:18 – Can bacteriophages replace antibiotics?

19:04 – Controlling rabies and hantavirus

28:33 – Diagnostic successes and failures from COVID-19

35:22 – How do we address vaccine hesitancy?

44:10 – Preparing for the next pandemic

47:03 – Rohde's three wishes for healthcare

In this episode, Jonathan Sackier is joined by Philip Hamann, Consultant Rheumatologist at North Bristol NHS Trust, UK. Known for his engaging TEDx talks and innovative work with AI-driven healthcare apps, Hamann discusses how big data, personalised medicine, and a holistic approach are revolutionising care for patients with rheumatoid arthritis.

Timestamps:

00:00 – Introduction

01:01 – Using humour to communicate science

06:02 – 'Living with Rheumatoid Arthritis': Hamann's award-winning app

14:43 – The cost of personalised medicine

19:07 – Real-world use of the app

26:05 – Importance of real-time data in rheumatology

33:10 – What does holistic care really mean?

40:07 – Hamann's three wishes for healthcare

In this episode, host Jonathan Sackier speaks with Alexander Spira about cutting-edge advances in lung and colorectal cancer, including EGFR and KRAS-targeted therapies. They also discuss Spira's leadership in oncology research, his thoughts on the evolving 'town-gown' dynamic in US medicine, and his hopes for the future of cancer care.

Timestamps: 00:00 – Introduction 01:50 – Most memorable family travel adventure 03:30 – What inspired you to go into oncology 05:49 – Three recent publications in lung cancer 07:02 – Real-world data on colorectal cancer 08:15 – Sex/gender differences in non-small cell lung cancer 11:53 – The science of KRAS mutations and drug development 15:07 – Accelerating diagnostics and access to therapies 17:13 – The 'town-gown' debate in American healthcare

18:09- Three Wishes

In this episode, Jonathan Sackier is joined by Adrian Owen, Professor of Cognitive Neuroscience and Imaging at the University of Western Ontario. They explore Owen's groundbreaking research on consciousness in vegetative states, the ethical questions raised by his work, and the cutting-edge technology that has changed our understanding of the brain.

Timestamps:

00:00 – Introduction

02:46 – Taking one album on a desert island

04:03 – A groundbreaking discovery about vegetative states

06:58 – Owen's bestseller: 'Into the Gray Zone'

11:18 – Where is the border between life and death?

15:40 – Cutting-edge technologies for brain imaging

20:11 – Applications of fMRI and EEG

24:41 – Does brain-training work?

31:09 – Implications for life support and end-of-life care

36:00 – Owen's three wishes for healthcare